• Mashup Score: 0
    AI for the Early Detection of Pathology - 2 year(s) ago

    The need for accurate and efficient diagnosis is growing.

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      The manual interpretation of #fundusimages can be time consuming and is prone to interobserver variability. Interest in the development of #AI-based systems for the automated interpretation of #fundus photographs is therefore growing. Read more: https://t.co/HbcbWe2e6Z https://t.co/de7aOZch7f

  • Mashup Score: 1
    AI for the Early Detection of Pathology - 2 year(s) ago

    The need for accurate and efficient diagnosis is growing.

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      The manual interpretation of #fundusimages can be time consuming and is prone to interobserver variability. Interest in the development of #AI-based systems for the automated interpretation of #fundus photographs is therefore growing. Read more: https://t.co/HbcbWe2e6Z https://t.co/J1hTrTS4BN

  • Mashup Score: 1
    Low IOP Cataract Surgery - 2 year(s) ago

    Emerging evidence suggests that maintaining a more physiologic IOP during cataract surgery can increase safety and efficiency.

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      Maintaining a physiologic #IOP during #cataractsurgery can provide significant benefits in terms of safety and surgical efficiency. Recent advances in phaco technology help in this pursuit and ensure a stable and controlled surgical environment. https://t.co/HVvGX3zsra https://t.co/BQWMzQ6P3V

  • Mashup Score: 1
    The Price of Progress - 2 year(s) ago

    At first blush, the idea of an ophthalmic surgical drug costing nearly as much as the professional fee for cataract surgery seems unreasonable. I was surprised to discover, for example, the cost of Omidria (phenylephrine and ketorolac intraocular solution 1%/3%; Rayner) was nearly equivalent to the professional fee associated with cataract surgery and was initially adamant that I wouldn’t use it….

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      For our field to progress, we #eyecare providers must incorporate the newest products, including those made available through a system designed to foster innovation. @Wiley2020 introduces the new issue of CRST: https://t.co/Xol9eHVsXC https://t.co/H4MRAA8mfr

  • Mashup Score: 0
    Alan W. Brown, MD - 2 year(s) ago

    Company: Surgilūm Clinical Practice: Surgical Eye Care, Wilmington, North Carolina Claim to Fame: A hidden inventor who created the world’s first laser target pendular corneal marker with preinked disposable marking tips Dr. Brown shares his journey developing the RoboMarker and building his company, Surgilūm. …

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      🕶️ Agent: @abrissettemd 📂 Company: Daily Practice 🥼 Clinical Practices: @NYPHospital + @WeillCornell This issue highlights our colleagues who have ventured beyond the OR to embrace their entrepreneurial spirit & personal passions! Watch: https://t.co/tRx6sbiPwz https://t.co/an0roEMq0D

  • Mashup Score: 0
    Social Media Use Among Ophthalmologists - 2 year(s) ago

    Social media has become an invaluable tool for patients and physicians alike, particularly millennial physicians who grew up and trained during the digital revolution.1 These doctors have embraced social media as both a personal and a professional networking tool. The COVID-19 pandemic accelerated this trend as traditional in-person interactions became less feasible. Ophthalmologists, like other…

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      To gain a deeper understanding of how #socialmedia is being used in this field, my colleagues & I sent a questionnaire to social media–using #ophthalmologists during the height of COVID-19 distancing measures. This article explores the results: https://t.co/htGwHq8W46 @DZEyeMD https://t.co/fra0Xv9jBa

  • Mashup Score: 0
    Ranya Habash, MD - 2 year(s) ago

    Companies: HIPAAChat, LifeLong Vision, MetaMed Clinical Practices: Bascom Palmer Eye Institute, Miami, and Stanford University School of Medicine, Palo Alto, California Claim to Fame: A digital health expert and visionary known for action and ability to see 10 steps ahead Dr. Habash shares her journey founding…

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      This issue highlights our colleagues who have ventured beyond the OR to embrace their entrepreneurial spirit & personal passions. https://t.co/JdI10d7GmG 🕶️ Agent: @JayPepose 📂 Company/Role: @ocuphire, Chief Medical Advisor 🥼 Clinical Practice: @PeposeVision, St. Louis https://t.co/y7gZltLA9O

  • Mashup Score: 0
    The Evidence: A Clinical Perspective on the HORIZON Trial - 2 year(s) ago

    Key 2- and 5-year outcomes from the HORIZON Clinical Trial and perspectives on how they apply to real-world practice.

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      Personalize your patient care with new clinical trial data from HORIZON. Read what Inder Paul Singh, MD; Brian Flowers, MD; and Pradeep Ramulu, MD, PhD have to say in this new supplement on CRST. https://t.co/y7hWpL3o1U #MIGS #glaucoma https://t.co/ScwAKe50KX

  • Mashup Score: 0
    Ranya Habash, MD - 2 year(s) ago

    Companies: HIPPAChat, LifeLong Vision, MetaMed Clinical Practices: Bascom Palmer Eye Institute, Miami, and Stanford University School of Medicine, Palo Alto, California Claim to Fame: A digital health expert and visionary known for action and ability to see 10 steps ahead Dr. Habash shares her journey founding…

    Source: CRSToday
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of CRSToday
      CRSToday

      This issue highlights our colleagues who have ventured beyond the OR to embrace their entrepreneurial spirit & personal passions. https://t.co/JdI10d7GmG 🕶️ Agent: @habash2020 📷 Companies: HIPPAChat, LifeLong Vision, MetaMed 📷 @BascomPalmerEye, @StanfordMed https://t.co/FFq2a2TL5a

Load More